Published in J Clin Microbiol on January 01, 1992
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 2.14
Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp. J Clin Microbiol (1993) 1.38
Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J Clin Microbiol (1996) 1.20
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. J Clin Microbiol (1995) 1.15
Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci. Appl Environ Microbiol (1995) 1.09
Expert systems in clinical microbiology. Clin Microbiol Rev (2011) 1.07
Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1993) 1.07
Use of the E test to predict high-level resistance to aminoglycosides among enterococci. J Clin Microbiol (1992) 1.01
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci. J Clin Microbiol (1998) 0.93
High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrob Agents Chemother (1993) 0.79
High-level aminoglycoside resistance and virulence characteristics among Enterococci isolated from recreational beaches in Malaysia. Environ Monit Assess (2013) 0.77
Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species. J Clin Microbiol (2003) 0.75
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med (1988) 16.74
The life and times of the Enterococcus. Clin Microbiol Rev (1990) 16.58
Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol (1989) 13.84
Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09
Vancomycin-resistant enterococci. Lancet (1988) 11.27
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother (1985) 7.83
High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis (1983) 6.01
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest (1983) 5.59
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis (1979) 4.70
Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol (1971) 3.59
Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob Agents Chemother (1987) 3.47
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother (1979) 3.42
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med (1989) 3.02
High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother (1988) 2.59
The enterococcus: "putting the bug in our ears". Ann Intern Med (1987) 2.59
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest (1971) 2.49
Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin. J Infect Dis (1988) 2.03
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci. Antimicrob Agents Chemother (1987) 1.86
Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrob Agents Chemother (1987) 1.68
Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis. J Clin Microbiol (1991) 1.36
Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species. J Clin Microbiol (1991) 1.30
Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp. J Clin Microbiol (1990) 1.27
Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards. J Clin Microbiol (1991) 1.19
Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J (1993) 11.30
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet (1986) 9.54
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol (1988) 8.18
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother (1994) 6.39
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet (1994) 5.73
The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet (1995) 4.63
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ (1998) 3.46
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother (1992) 3.31
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.19
Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A (1999) 2.91
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Evaluation of new medium, oxacillin resistance screening agar base, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J Clin Microbiol (2001) 2.64
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Combined spinal and extradural anesthesia. Anesth Analg (1992) 2.47
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol (2000) 2.39
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Ultrasonography of the rotator cuff. A comparison of ultrasonographic and arthroscopic findings in one hundred consecutive cases. J Bone Joint Surg Am (2000) 2.30
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother (2000) 2.22
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol (1999) 2.22
Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol (2002) 2.19
A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis (1997) 2.14
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis (1994) 2.09
Problems with rapid agglutination methods for identification of Staphylococcus aureus when Staphylococcus saprophyticus is being tested. J Clin Microbiol (1988) 2.09
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
Trial of relaxation in reducing coronary risk: four year follow up. Br Med J (Clin Res Ed) (1985) 2.07
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol (2008) 2.03
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
Bacterial meningitis in children and adults. Changes in community-acquired disease may affect patient care. Postgrad Med (1998) 2.00
The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc (1996) 1.97
Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A (1996) 1.95
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med (2006) 1.91
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother (2000) 1.89
The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol (2001) 1.88
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci (2001) 1.86
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med (1992) 1.85
PCR detection of Escherichia coli O157:H7 directly from stools: evaluation of commercial extraction methods for purifying fecal DNA. J Clin Microbiol (2000) 1.84
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health (1993) 1.83
Evaluation of the circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. AJNR Am J Neuroradiol (1995) 1.78
Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene. Science (1985) 1.77
Benefit of intravenous antispasmodic (hyoscyamine sulfate) as premedication for colonoscopy. Gastrointest Endosc (1999) 1.76
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother (1996) 1.74
Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol (1999) 1.73
Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene (1992) 1.73
Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis (1994) 1.70
Agr-related sequences in Staphylococcus lugdunensis. FEMS Microbiol Lett (1993) 1.70
Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med (2001) 1.70
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol (2006) 1.69
Cloning and nucleotide sequence of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin-resistant strain of Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.67
Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res (1989) 1.67
Endocarditis caused by M6. J Clin Microbiol (1983) 1.67
Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics (2000) 1.66
Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol (1995) 1.66
Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol (1997) 1.65
Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J Infect Dis (1993) 1.62
Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus. J Clin Microbiol (1992) 1.62
Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol (1997) 1.61
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1990) 1.59
Genetic diversification of methicillin-resistant Staphylococcus aureus as a function of prolonged geographic dissemination and as measured by binary typing and other genotyping methods. Res Microbiol (1998) 1.58
The spectrum of HIV-1 related cancers in South Africa. Int J Cancer (2000) 1.58
In vitro susceptibility of Acinetobacter baumannii to biapenem, piperacillin/tazobactam and thirteen other antimicrobial agents. Eur J Clin Microbiol Infect Dis (1994) 1.56